|
|
Volumn 10, Issue 1, 2000, Pages 59-66
|
|
Novel antidiabetic agents
|
|
Author keywords
Gluconeogenesis; Glycogenolysis; Hypoglycaemic agents; Insulin secretagogues; Insulin sensitisers; Type 2 diabetes
|
|
Indexed keywords
3 [4 [2 (5 METHYL 2 PHENYL 4 OXAZOLYL)ETHOXY]PHENYL] 2 PROPYLAMINOPROPIONIC ACID;
6 [[2 [[2 (2 CYANO 1 PYRROLIDINYL) 2 OXOETHYL]AMINO]ETHYL]AMINO]NICOTINONITRILE;
ANTIDIABETIC AGENT;
BEXAROTENE;
CIGLITAZONE;
GLIBENCLAMIDE;
GLUCOSE;
GLUCOSE 6 PHOSPHATE INHIBITOR;
INSULIN;
MEGLITINIDE;
N (2 BENZOYLPHENYL) O [2 (METHYL 2 PYRIDINYLAMINO)ETHYL]TYROSINE;
NATEGLINIDE;
PIOGLITAZONE;
REGLITAZAR;
REPAGLINIDE;
RETINOID X RECEPTOR;
RETINOID X RECEPTOR STIMULATING AGENT;
ROSIGLITAZONE;
THIAZOLIDINE DERIVATIVE;
TROGLITAZONE;
UNCLASSIFIED DRUG;
BLOOD GLUCOSE MONITORING;
CLINICAL TRIAL;
DIABETES MELLITUS;
DIABETIC NEPHROPATHY;
DIABETIC NEUROPATHY;
DIABETIC RETINOPATHY;
DRUG CLEARANCE;
HUMAN;
HYPERGLYCEMIA;
INSULIN RELEASE;
INSULIN RESISTANCE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PATENT;
REVIEW;
|
|
EID: 0033986879
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.10.1.59 Document Type: Review |
|
Times cited : (11)
|
|
References (125)
|
